Category Archives: Meetings

The Truth About Closed-Loop Marketing

By Brittany Agro | Published: September 12, 2008
Pharma sales forces were out, well, in force for a two-day leadership summit put on by the Center for Business Intelligence this week in Philadelphia. As a newbie on the pharma reporting scene, I eagerly await these conference opportunities…especially the ones that deal with important sales management topics. This conference, in particular, presented sessions on [...]
Also posted in Marketing, Sales | Tagged , , , , , , , , | Leave a comment

High-Tech Name Tags (and More) From re:think08

By Brittany Agro | Published: August 26, 2008
Call me old-fashioned, but the one low-tech item I never expected to see threatened with extinction was the humble but indispensable business card. After Last Thursday’s re:think08, the fifth edition of the seminar on event marketing and team building put on by the communications company Impact Unlimited, I’m not so sure. The event had some [...]
Also posted in Deals, Strategy, Technology | Tagged , , , , | 3 Comments

PRSA Day 2: Join the Conversation

By Joanna Breitstein | Published: April 4, 2008
The second dispatch from Marina Maher Communication’s healthcare guru Megan Svensen: It’s the second day of the 19th Annual PRSA Health Academy meeting in Chicago and the morning has provided more valuable learnings. Ed Schipul, CEO of Schipul – The Web Marketing Company, gave a great analogy in his talk: He says joining the blogosphere [...]
Also posted in E-Media, Marketing | 3 Comments

PRSA Day 1: Talking’ Cross Gen

By Joanna Breitstein | Published: April 4, 2008
The discussions over the next model for pharma fall all over the map, but include one central component: a conversation with consumers. How to do it? Here, Megan Svensen, executive vice president of healthcare for Marina Maher Communications, reports in from the annual Public Relations Society of America boot camp on healthcare. I’m coming to you [...]
Also posted in Marketing | Leave a comment

ACC News Echoes Cost/Benefit Concerns

By Joanna Breitstein | Published: March 31, 2008
News flowing from the American College of Cardiology meeting has been dominated by Vytorin. And after the presentation analyzing results yesterday, Miller Tabak analyst Les Fundleyter says, “We’re done for the conference in terms of the important stuff. Vytorin is the story this year.” So what is Vytorin’s story exactly? Industry watchers say they are still [...]
Also posted in R&D, Regulatory | 1 Comment